Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Prednisone and BMT vs Maintenance in ALL (ALL-4)
NCT00002700Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 1995
- Primary completion
- Mar 2004
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial of dexamethasone and prednisone in acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL) (5 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoints: Rate of Remission Induction, Incidence of Toxicity and 3 more. Started Aug 1995; status: completed.
02
Drugs
dexamethasoneprednisone
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT00002700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002700.